Astrana Health (ASTH)

• Market cap: $1.34B
• 1 day: -5.80%
• 5 days: -11.47%
• 1 month: -4.31%
• 3 months: -20.41%
• 6 months: -50.82%
• Year to date: -8.20%
• 1 year: -21.03%
• 5 years: 122.59%
• 10 years: 195.60%
• Sector: Healthcare
• Industry: Medical Care Facilities

About: Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

Employees: 1,900

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

1,466% more call options, than puts

Call options by funds: $14.4M | Put options by funds: $921K

24% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 54

1.3% more ownership

Funds ownership: 45.0% [Q3] → 46.31% (+1.3%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]

6% less funds holding

Funds holding: 189 [Q3] → 178 (-11) [Q4]

24% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 41

44% less capital invested

Capital invested by funds: $1.47B [Q3] → $822M (-$644M) [Q4]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $36 22% upside
• Avg. target: $47 60% upside
• High target: $56 89% upside

5 analyst ratings

• positive: 4 80%
• neutral: 1 20%
• negative: 0 0%

Barclays Andrew Mok 46% 1-year accuracy 26 / 57 met price target	22% upside $36	Equal-Weight Initiated	1 Apr 2025
Truist Securities Jailendra Singh 34% 1-year accuracy 12 / 35 met price target	56% upside $46	Buy Maintained	18 Mar 2025
B of A Securities Adam Ron 75% 1-year accuracy 3 / 4 met price target	66% upside $49	Buy Maintained	4 Mar 2025
Baird Michael Ha 55% 1-year accuracy 12 / 22 met price target	69% upside $50	Outperform Maintained	3 Mar 2025
Stifel Craig Jones 60% 1-year accuracy 6 / 10 met price target	89% upside $56	Buy Maintained	20 Feb 2025